Ovobel Foods Limited (BOM:530741)
188.25
+1.05 (0.56%)
At close: Jul 20, 2026
Ovobel Foods Revenue
In the fiscal year ending March 31, 2026, Ovobel Foods had annual revenue of 2.57B INR with 36.14% growth. Ovobel Foods had revenue of 650.24M in the quarter ending March 31, 2026, with 35.85% growth.
Revenue
2.57B
Revenue Growth
+36.14%
P/S Ratio
0.70
Revenue / Employee
20.22M
Employees
127
Market Cap
1.81B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.57B | 681.63M | 36.14% |
| Mar 31, 2025 | 1.89B | 139.68M | 8.00% |
| Mar 31, 2024 | 1.75B | -467.22M | -21.11% |
| Mar 31, 2023 | 2.21B | 962.55M | 76.95% |
| Mar 31, 2022 | 1.25B | 143.61M | 12.97% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rikhav Securities | 19.86B |
| Trigyn Technologies | 9.76B |
| Shivam Chemicals | 2.84B |
| Jasch Industries | 2.29B |
| Star Delta Transformers | 1.73B |
| Comfort Intech | 1.45B |
| Jhaveri Credits and Capital | 1.19B |
| Oxygenta Pharmaceutical | 1.13B |